CrunchBase is hiring! Check out our open positions →
Register | Login or Login

Funds

Offices

Tags

GSK Venture Fund

No overview yet.

Recent Milestones

Investments

Company Date Round Size Participants
SpingLeaf Therapeutics 5/11Series B$15M1
Anacor Pharmaceutical 7/10Venture Round$15M1
diaDexus 2/09Series F$9.2M3
Anacor Pharmaceutical 1/09Series E$50M6
Concert Pharmaceuticals 4/08Series C$37M12
CalciMedica 8/07Series B$5.5M2
diaDexus 1/07Series E$40M7
Resistentia Pharmaceuticals 9/06Series C$14M5
Trinity Biosystems 7/06Series B$21M4

Videos

Sources

  1. GSK venture group backs SpringLeaf in $15M round (fiercebiotech.com) [edit]
  2. Anacor gets $15M from GSK (fiercebiotech.com) [edit]
  3. diaDexus lands $9.2M for cardiovascular diagnostics (deals.stage.venturebeat.com) [edit]
  4. Anacor Raises $50 Million in Equity Financing (bio-medicine.org) [edit]
  5. Capital Funding Report [edit]
  6. EDGAR [edit]
  7. DiaDexus Raises $40M Series E For Expansion (scalevp.com) [edit]
  8. EDGAR [edit]
  9. EDGAR [edit]
Edit This Page
Last Edited 4/30/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

Recent Incoming Links

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy